Trial intelligence / Profile preview

Nalbuphine versus fentanyl in non-mechanically ventilated ICU patients

ChiCTR1800019763Phase 4Recruiting

Sponsor
The First Affiliated Hospital of Zhengzhou University
Start
Dec 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of nalbuphine and fentanyl in pain (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoint: CPOT score. Started Dec 2018; status: recruiting.

02

Drugs

nalbuphinefentanyl
03

Conditions

pain

Beyond the preview

Go deeper on ChiCTR1800019763.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1800019763.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call